Document is current
Any future updates will be listed below
-
Authors
Ahmadi Bidakhvidi, Niloefar https://orcid.org/0000-0002-2225-0161
Lara Jimenez, Elena https://orcid.org/0009-0006-7026-6535
Leupe, Hannes https://orcid.org/0000-0001-9080-2370
Jentjens, Sander https://orcid.org/0000-0003-3602-9078
Baldewijns, Marcella https://orcid.org/0000-0002-0882-2944
De Schepper, Maxim https://orcid.org/0000-0001-9829-8535
Laenen, Annouschka https://orcid.org/0000-0002-1371-442X
Devos, Gaëtan https://orcid.org/0000-0002-6772-915X
Giesen, Alexander https://orcid.org/0000-0002-3345-4573
Koole, Michel https://orcid.org/0000-0001-5862-640X
Deroose, Christophe M. https://orcid.org/0000-0002-6080-1577
Everaerts, Wouter https://orcid.org/0000-0002-3157-7115
Joniau, Steven https://orcid.org/0000-0003-3195-9890
Goffin, Karolien https://orcid.org/0000-0002-7453-0229
-
Funding
Funding for this research was provided by:
Agentschap voor Innovatie door Wetenschap en Technologie (IWT.140193)
- License Information
-
More Information
Article History
Received: 11 August 2025
Accepted: 25 November 2025
First Online: 9 January 2026
Declarations
:
: This study was approved by the Ethics Committee Research UZ/KU Leuven (EC Research; study number S59428) and complied with the declaration of Helsinki.
: Informed consent was obtained from all individual participants included in this study.
: Christophe M. Deroose is an employee of UZ Leuven. He is/has been a consultant for (fees received by institution): Sirtex, Advanced Accelerator Applications, Novartis, Ipsen, Terumo, PSI CRO, Immedica Pharma, Molecular Partners, Nuclear Research and consultancy. His institution has received travel fees from: GE Healthcare, Sirtex. The other authors have no relevant financial or non-financial interests to disclose.
